
W-54011
CAS No. 405098-33-1
W-54011 ( W54011 | W 54011 | W-54011 )
产品货号. M14391 CAS No. 405098-33-1
一种有效的口服活性非肽 C5a 受体 (CD88;C5aR) 拮抗剂,Ki 为 2.2 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1272 | 有现货 |
![]() ![]() |
10MG | ¥1920 | 有现货 |
![]() ![]() |
25MG | ¥3629 | 有现货 |
![]() ![]() |
50MG | ¥5403 | 有现货 |
![]() ![]() |
100MG | ¥7687 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称W-54011
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述一种有效的口服活性非肽 C5a 受体 (CD88;C5aR) 拮抗剂,Ki 为 2.2 nM。
-
产品描述A potent and orally active non-peptide C5a receptor (CD88;C5aR) antagonist with Ki of 2.2 nM; also inhibits C5a-induced intracellular Ca(2+) mobilization, chemotaxis, and generation of reactive super oxide species in human neutrophils with IC50 of 3.1, 2.7, and 1.6 nM, respectively; inhibits C5a-induced neutropenia in gerbils (3-30 mg/kg).
-
体外实验In C5a-induced intracellular Ca2+ mobilization assay with human neutrophils, W-54011 does not show agonistic activity at up to 10 μM and shifts rightward the concentration-response curves to C5a without depressing the maximal responses, indicating that W-54011 is a full antagonist. At concentrations up to 10 μM, W-54011 does not affect Ca2+ mobilization stimulated with sub-maximally effective concentrations of fMLP (1 nM), plateletactivating factor (0.3 nM), and IL-8 (0.1 nM). This result demonstrates that W-54011 is highly specific for C5a receptor.
-
体内实验W-54011 (3-30 mg/kg; oral administration; for 4 hours; male mongolian gerbils) treatment inhibited C5a-induced neutropenia in a dose-dependent manner in gerbils.The species selectivity of W-54011 is examined in rhC5a-induced intracellular Ca2+ mobilization of neutrophils in various species. The W-54011 is able to inhibit the response in cynomolgus monkeys and gerbils with IC50 values of 1.7 nM and 3.2 nM, respectively, but not in mice, rats, guinea pigs, rabbits, and dogs. Animal Model:Male mongolian gerbils (6-12 weeks) injected with rhC5a Dosage:3 mg/kg, 10 mg/kg, 30 mg/kg Administration:Oral administration; for 4 hours Result:Inhibited C5a-induced neutropenia in a dose-dependent manner.
-
同义词W54011 | W 54011 | W-54011
-
通路Immunology/Inflammation
-
靶点Complement System
-
受体Complement System
-
研究领域Other Indications
-
适应症——
化学信息
-
CAS Number405098-33-1
-
分子量493.08
-
分子式C30H37ClN2O2
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 28 mg/mL
-
SMILESO=C(C1CCCC2=C1C=C(OC)C=C2)N(CC3=CC=C(N(C)C)C=C3)C4=CC=C(C(C)C)C=C4
-
化学全称1-Naphthalenecarboxamide, N-[[4-(dimethylamino)phenyl]methyl]-1,2,3,4-tetrahydro-7-methoxy-N-[4-(1-methylethyl)phenyl]-, hydrochloride (1:1)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Sumichika H, et al. J Biol Chem. 2002 Dec 20;277(51):49403-7.
2. Kurihara R, et al. Inflamm Res. 2010 Aug;59(8):659-66.
3. Sendler M, et al. Gastroenterology. 2015 Sep;149(3):765-76.e10.
产品手册




关联产品
-
Sutimlimab
Sutimlimab 是首创的补体蛋白成分 1,s 亚成分 (C1s)抑制剂,可用于冷凝集素综合征的研究。C1s 是一种丝氨酸蛋白酶,可切割 C4 和 C2 以形成 C3 转化酶。
-
BCX-1470 methanesulf...
一种丝氨酸蛋白酶抑制剂,可抑制因子 D (IC50=96 nM) 和 C1s (IC50=1.6 nM) 的酯解活性。
-
NDT 9513727
NDT 9513727 是一种有效的、选择性的、口服生物可利用的 C5a 受体反向激动剂,在放射性配体结合测定中 IC50 为 11.6 nM。